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Abstract
Our studies using immature rat granulosa cells cultured in serum-free medium on collagen-coated dishes indicated that
FSH receptor mRNA levels do not change for at least 4 days of culture in the absence of hormone treatment. Addition of
 y1 .  .FSH 30 ng ml led to a reduction of FSH receptor mRNA for a short time 6 h , followed by an increase in FSH receptor
mRNA levels that reached maximum of around 200% of the initial level within 2–3 days after the addition of FSH.
Following the addition of 10 nM PMA, FSH receptor mRNA levels were decreased to 50% of the pretreatment levels.
During prolonged exposure to PMA, gradual recovery of the FSH receptor mRNA level was observed, and it was
significantly higher than the control level at 48 h. The inactive phorbol ester 4 a-phorbol-12,13-didecanoate did not depress
FSH receptor mRNA levels. Downregulation of the FSH receptor mRNA was detectable at a PMA concentration of 1 nM.
The two predominant FSH receptor mRNA transcripts, ca. 5.5 and 2.4 kb, respectively, appeared to be equally affected by
SH and PMA treatments. To examine the role of PKC mediation of the effect of FSH on FSH receptor mRNA levels,
granulosa cells were treated with the PKC inhibitor, H-7, and FSH. Although, FSH receptor mRNA levels decreased to 50%
 .of control in the cells treated with FSH alone, the addition of H-7 0.1 nM caused no decline in FSH receptor mRNA levels
relative to the control in the cells treated with FSH. On the other hand, inhibition of FSH receptor mRNA by FSH was
partially suppressed by the PKC-selective inhibitor bisindolylmaleimide. The mRNA turnover experiments showed that the
half-life of FSH receptor transcripts was unaffected by PMA exposure. q 1997 Elsevier Science B.V.
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1. Introduction
Ovarian granulosa cells undergo a complete differ-
entiation process during the growth and maturation of
ovarian follicles. This process includes the acquisi-
tion of FSH receptors in the early stages of follicular
growth, and the induction of FSH receptors in granu-
) Corresponding author. Fax: q81-272-208443.
losa cells is a critical step in reproductive physiology.
Data from several laboratories, including our own,
have shown that FSH, a major regulator of FSH-re-
ceptor induction, increases FSH receptor mRNA lev-
w xels both in vivo and in vitro 1–4 . Many of the FSH
effects on granulosa cells are mediated by the cAMP
w xsecond messenger system 5 . A model system that
has been widely used to study this phenomenon
consists of primary cultures of rat granulosa cells
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obtained from immature female rats pretreated with
estradiol. By using this defined system, the ability of
FSH to stimulate induction of FSH-receptors has
been shown to be mediated, at least in part, by
cAMP, since exogenous cAMP or other agents that
increase intracellular levels of cAMP mimic the ac-
w xtions of FSH 4 . It is generally assumed that FSH
acts on adenylyl cyclase through the stimulating
GTP-binding protein Gs, resulting in increased levels
of cAMP. However, the glycoproteins including FSH
appear to exhibit distinct dual signaling with cAMP
and calcium, representing parallel independent sig-
w xnals 6–8 . Moreover, in a previous experiment, we
observed that FSH induced a rapid rise in cytosolic
calcium in a cell line stably transfected with the
w xhuman FSH receptor cDNA 9 .
Using rat granulosa cell culture system, we have
investigated the mechanism of downregulation of
FSH receptor mRNA. Since this effect was not medi-
ated by cAMP, it appeared to involve other second
messenger pathways coupled to FSH receptors.
 .Moreover, the fact that protein kinase C PKC activ-
ity has been demonstrated in both follicular and luteal
tissue suggests that the enzyme plays an important
w xrole in gonadal functions 10,11 . However, the
physiological significance of PKC activity is less
clear. To clarify the physiological significance of the
activity of PKC coupled to FSH receptor in this
study, we examined the effect of the PMA on FSH
receptor mRNA, and the effect of the
serinerthreonine inhibitors, 1- 5-isoquinoline sul-
.  .fanyl -2-methylpiperazine H-7 and bisindolyl-
maleimide on FSH-induced downregulation of FSH
receptor mRNA. The results presented demonstrate
that FSH mediated PKC activation play a significant
role in transient decrease in FSH receptor mRNA
levels.
2. Materials and methods
2.1. Hormones and reagents
w xRat FSH 1–8 was obtained from the National
Hormone and Pituitary Distribution Program Be-
.  .thesda, MD . Diethylstilbestrol DES , gentamicin
 .sulfate, phorbol 12-myristate-13-acetate PMA and
 .4a-phorbol-12,13-didecanoate 4a-PDD were pur-
 .chased from Sigma St. Louis, Mo . H-7 was pur-
 .chased from Seikagaku Tokyo, Japan . Dulbecco’s
 .modified Eagle DEM medium, Hams F-12 medium,
and fungizone were purchased from GIBCO Grand
.Island, NY . The RNA labeling kit, nucleic acid
detection kit and bisindolylmaleimide were purchased
 .from Boehringer Mannheim Mannheim, Germany .
2.2. Rat granulosa cell culture
Granulosa cells were obtained from immature fe-
male Wistar rats which received an injection of 2 mg
diethylstilbestrol in 0.1 ml sesame oil once daily for 4
days. The ovaries were then excised, and granulosa
cells were released by puncturing follicles with a 25
gauge needle. At all times, the animals were treated
as humanely as possible, following NIH guidelines.
Granulosa cells were washed and collected by brief
centrifugation, and cell viability was determined by
trypan blue exclusion. The granulosa cells were then
 .cultured in Ham’s F-12rDME 1:1 volrvol medium
supplemented with 1.1 g ly1 NaHCO , 40 mg ly13
gentamycin sulfate, 1 mg ly1 fungizone, and 100 mg
ly1 BSA on collagen coated plates in a humidified
w xatmosphere containing 5% CO 95% air at 378C 12 .2
2.3. Preparation of cRNA probes
Rat FSH receptor cDNA was subcloned into the
 .EcoR1 site of the Bluescript KS q vector and lin-
w xearized with HindIII 12 . Digoxigenin-labeled FSH
receptor cRNA probes corresponding to bases 239–
2368 were produced by in vitro transcription with T7
RNA polymerase and an RNA labeling kit Boeh-
.ringer Mannheim . A digoxigenin labeled b-actin
cRNA probe was obtained by the same method.
2.4. RNA isolation and analysis
Granulosa cells were cultured in 60 mm dishes
containing 5=106 viable cells in 5 ml of medium,
and reagents were added to the medium after 24 h of
cell culture. The granulosa cells were further incu-
bated, and the cultures were stopped at the selected
time as indicated in the guanidinium acid–
w xthiocyanate–phenol–chloroform method 13 . The fi-
nal RNA pellet was dissolved in diethyl pyrocabon-
ate-treated H O. Total RNA was quantified by mea-2
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suring the absorbance of samples at 260 nm. For
Northern blot analysis, 15 mg total RNA from each
dish were separated by electrophoresis on denaturing
agarose gels and subsequently transferred to a nylon
 .membrane Biodyne, ICN . In accordance with the
standard protocol for the nucleic acid detection kit
 . Boehringer Mannheim , Kodak X-Omat film East-
.man Kodak, Rochester, NY was then exposed to the
membranes. The relative abundance of a 2.4 kilobase
 .kb signal in different preparations were quantified
with a LKB 2202 UnitroScan Laser Densitometer
 .LKB Produkter AB, Bromma, Sweden and normal-
ized against levels of b-actin mRNA in each sample
 .and expressed as relative to the control value 100% .
2.5. Transcription stability analysis
Cells were preincubated with or without PMA for
6 h before the addition of 5 mM actinomycin-D, to
arrest new RNA synthesis. Cells were harvested 0, 3,
6, 9 and 12 h after addition of actinomycin-D for
RNA extraction and Northern blot analysis was per-
formed as described above.
2.6. Data analysis
For Northern blot, all experiments were repeated
three times, with one representative experiment pre-
sented. The data are presented as the mean"SE of
measurements from triplicate cultures. Differences
between control and treated cells were assessed by
Student’s t-test for independent samples.
3. Results
Northern blot analysis indicated the presence of
two predominant FSH receptor mRNA transcripts of
approximately 5.5 and 2.4 kb, respectively, in total
w xRNA prepared from rat granulosa cells 12 . No
change in FSH receptor mRNA was apparent in our
system in the absence of hormone treatment Fig.
.1A . There was an increase in the level of FSH
receptor mRNA in the presence of 30 ng mly1 FSH,
and this approximately 1.8-fold increase was evident
 .2–3 days after addition of the hormone P-0.05
 .Fig. 1B . More detailed time-course studies showed
that FSH treatment decreased FSH receptor mRNA
Fig. 1. Effect of FSH treatment on FSH receptor mRNA in
 .  .cultured granulosa cells. A Total RNA 15 mg was prepared
 .from cells immediately before 0 h or at the indicated days after
 y1.addition of FSH 30 ng ml . Northern blots were performed to
analyze the levels of FSH receptor with FSH receptor cRNA
 .  .probe. B The level of FSH receptor 2.4 kb and b-actin mRNA
were analyzed by scanning the autoradiograms with a laser
 .densitometer. FSH mRNA levels with 0 day defined as 100%
are expressed relative to b-actin mRNA. The data shown the
average"SEM of three experiments.
levels by a maximum of about 50% of the control at
 .6 h P-0.05 , and that they gradually increased
after 6 h, returning to the control level by 24 h, and
 .continued to increase after 24 h Fig. 2B . The results
show that addition of FSH leads to a reduction of
FSH receptor mRNA during short term incubation,
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Fig. 2. Effect of FSH treatment on FSH receptor mRNA in
cultured granulosa cells during the time course of downregula-
 .  .tion. A Total RNA 15 mg was prepared from cells immedi-
 . ately before 0 h or at the indicated h after addition of FSH 30
y1.ng ml . Northern blots were performed to analyze the levels of
 .FSH receptor with FSH receptor cRNA probe. B The level of
 .FSH receptor 2.4 kb and b-actin mRNA were analyzed by
scanning the autoradiograms with a laser densitometer. FSH
 .mRNA levels with 0 day defined as 100% are expressed
relative to b-actin mRNA. The data shown the average"SEM of
three experiments.
and this observation of the decrease of FSH receptor
w xmRNA confirmed our previous data 14 . On the
other hand, the level of FSH receptor mRNA subse-
quently increased and reached a maximum of around
200% of the initial level within 3 days of the addition
of FSH. These results showed a rapid and transient
downregulatory effect of FSH on FSH receptor
mRNA, and at the same time this dose of FSH
increased FSH receptor mRNA during incubation
 .after 24 h Fig. 2A .
Although we showed a transient downregulatory
effect of PMA on FSH receptor mRNA in previous
experiments, the possible effects of PMA on FSH
receptor mRNA accumulation were examined under
the same experimental conditions during a longer
period of incubation. There was a rapid decrease in
the level of FSH receptor mRNA, following the
 .addition of 10 nM PMA to granulosa cells Fig. 3A .
This decline in FSH receptor mRNA levels is so
marked that at 5–10 h the levels are reduced to 50%
 .below the pretreatment level P-0.01 . However, a
gradual recovery of FSH receptor mRNA levels was
observed during prolonged exposure to PMA, and the
level was significantly higher than the control level
 .  .by 48 h P-0.01 Fig. 3B .
The dose-dependence of FSH receptor mRNA re-
pression in response to PMA was investigated by
Northern blotting. The biologically inactive phorbol
ester 4a-PDD did not modify FSH receptor mRNA
content, thereby confirming a specific action of phor-
 .bol esters to stimulate PKC Fig. 4A . Downregula-
tion of the FSH receptor was detectable at a PMA
 .  .concentration of 1 nM P-0.01 Fig. 4B . The two
predominant FSH receptor mRNA transcripts of ca.
5.5 and 2.4 kb appeared to be equally affected by
PMA treatment.
To examine the role of PKC mediation in the
effect of FSH on FSH receptor mRNA levels, granu-
losa cells were treated with FSH and the PKC in-
hibitor, H-7. Although, FSH receptor mRNA levels
decreased to 50% of the control in the cells treated
 .with FSH, the addition of H-7 0.1 nM caused no
decline in FSH receptor mRNA levels relative to
 .control in the cells treated with FSH Fig. 5A .
 .Moreover, administration of H-7 1 nM in the pres-
ence of FSH significantly increased FSH receptor
 . mRNA compared with the control P-0.05 Fig.
.5B . We also studied the reversibility of the FSH-in-
duced decrease in FSH receptor mRNA content pro-
duced by a recently characterized PKC inhibitor,
bisindolylmaleimide, which acts as a competitive in-
hibitor with respect to the ATP binding site on the
w xcatalytic moiety of the kinase 15 . In contrast with
other PKC inhibitors, this novel compound displays
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high selectivity for classical isoforms of PKC, as
compared to several other protein kinases. When cells
were exposed to this inhibitor with the addition of
FSH, the decrease in FSH receptor mRNA content
induced by 30 ng mly1 of the hormone, was around
 .50% Fig. 6B .
Fig. 3. Time course of change in FSH receptor in FSH mRNA
 .  .levels after the addition of PMA. A Total RNA 15 mg was
extracted from granulosa cells at the selected times after the
 .addition of PMA 10 nM . Northern blots were preformed to
analyze the levels of FSH receptor mRNA with FSH receptor
cRNA probe. The Northern blot is representative of three repli-
 .  .cate experiments. B The level of FSH receptor 2.4 kb and
b-actin mRNA were analyzed by scanning the autoradiograms
with a laser densitometer. FSH mRNA levels with 0 h defined as
.100% are expressed relative to actin mRNA. The data shown the
average"SEM of three experiments.
Fig. 4. Effect of PMA concentration on FSH receptor mRNA
levels. Granulosa cells were treated for 6 h in the absence of
 .presence of 4 a-PDD and PMA. Total RNA 15 mg was
prepared and Northern bolts were performed to analyze the levels
 .of FSH receptor mRNA with FSH receptor cRNA. B The level
 .of FSH receptor 2.4 kb and b-actin mRNA were analyzed by
scanning the autoradiograms with a laser densitometer. FSH
 .mRNA levels with medium alone defined as 100% are ex-
pressed relative to actin mRNA. The data shown the average"
SEM of three experiments.
The PMA-induced decrease in FSH receptor
mRNA levels resulted either from a decreased rate of
gene transcription, accelerated rate of RNA degrada-
tion, or a combination of both. We therefore exam-
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ined the turnover of the FSH receptor mRNA in
granulosa cells exposed to FSH and a transcription
 .inhibitor actinomycin-D in the absence and pres-
Fig. 5. Effects of protein kinase inhibitor H-7 on FSH-induced
 .decreases in FSH receptor mRNA level. A Granulosa cells were
treated for 6 h in the absence or presence of FSH with increasing
 .  .concentrations of H-7. B The level of FSH receptor 2.4 kb
and b-actin mRNA were analyzed by scanning the autoradio-
grams with a laser densitometer. FSH mRNA levels with medium
.alone defined as 100% are expressed relative to b-actin mRNA.
The data shown the average"SEM of three experiments.
Fig. 6. Effects of protein kinase inhibitor bisidolylmaleimide on
 .FSH-induced decreases in FSH receptor mRNA level. A Granu-
losa cells were treated for 6 h in the absence or presence of FSH
with increasing concentrations of bisidolylmaleimide. Total RNA
 .15 mg was prepared and Northern blots were performed to
analyze the levels of FSH receptor mRNA with FSH receptor
 .  .cRNA. B The level of FSH receptor 2.4 kb and b-actin
mRNA were analyzed by scanning the autoradiograms with a
laser densitometer. FSH mRNA levels with medium alone de-
.fined as 100% are expressed relative to actin mRNA. The data
shown the average"SEM of three experiments.
ence of PMA. The disappearance of FSH receptor
transcripts were then assayed by Northern analysis
 .over a 4-h period Fig. 7A . The rate of receptor
mRNA decay in PMA-treated granulosa cells was no
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 .Fig. 7. Effect of PMA on FSH-receptor mRNA transcript. A
 y1.Granulosa cells were preincubated with PMA 10 nM ml for
6 h before the addition of 5 mM actinomycin-D at zero time to
arrest new RNA synthesis. Cells were harvested 0, 3, 6, 9 and 12
h after addition of actinomycin-D for RNA extraction. Northern
blots were performed to analyze the levels of FSH-receptor
 .mRNA with the FSH-receptor cRNA probe. B FSH receptor
 .2.4 kb and b-actin mRNA levels were analyzed by densito-
metric scanning. Data were normalized for b-actin mRNA levels
in each sample and expressed relative to the control value. The
Northern blot is representative of three replicate experiments and
the data are presented as means"SE measurements. The degra-
dation curves of the 2.4 kb FSH receptor mRNA transcript are
shown for control and PMA-pretreated cells. The mRNA levels at
time zero were assigned a relative value of 100%, and mRNA
levels at all other times are expressed as percentages of time 0
values. The ordinate is plotted on a logarithmic scale.
different from that observed in the control cells Fig.
.7B , strongly suggesting that PMA caused a decrease
in FSH receptor gene expression by inhibiting gene
transcription, rather than by a decrease in mRNA
stability.
4. Discussion
The results of our studies using immature rat
granulosa cells cultured in serum-free medium on
collagen-coated dishes indicated that FSH receptor
mRNA levels did not change during at least 4 days of
culture in the absence of hormone treatment. The
previous reports, however, claimed that a time-related
decrease in the level of FSH receptor mRNA was
observed after increasing lengths of culture in the
absence of hormone treatment, compared to the levels
w xfound in cells at the start of culture 4,16 . In contrast
to these findings, an other group reported that binding
of FSH to cells cultured without addition of stimula-
w xtor increased 6.5 fold 17 . Therefore, the level of
FSH receptor expression in untreated cells may de-
pend on the characteristics of the culture system.
The results of our experiments indicated that FSH
increased the levels of its own receptor mRNA under
the same culture conditions. This stimulatory effect
of FSH on its own receptor mRNA levels is consis-
tent with in vivo studies demonstrating the ability of
FSH to increase the level of its own receptor mRNA
w x1,2 . The stimulatory effect of cholera toxin and
forskolin, which increase intracellular cAMP concen-
trations, suggests that cAMP is involved in up-regu-
lation of the FSH receptor. In addition, in our previ-
ous experiment, we showed that 8-Br–cAMP in-
creased the level of FSH receptor mRNA in this
w xgranulosa cell culture system 18 . The results of the
nuclear run-on experiments presented clearly demon-
strated that 8-Br–cAMP significantly stimulates the
rate of transcription of the FSH receptor gene in
granulosa cells. The increased FSH receptor gene
transcription elicited by 8-Br–cAMP suggests that
FSH mediates this effect through the cAMP pathway.
Since the rate at which this mRNA decayed was
unchanged relative to the untreated control cells, the
rapid increase in FSH-receptor mRNA levels induced
by cAMP is the result of enhanced transcription of
w xthe FSH receptor gene 19 .
On the other hand, FSH receptor levels in Sertoli
cells are negatively modulated by FSH during a short
incubation periods. cAMP has been shown to cause a
decrease in the rate of transcription of the FSH
receptor gene, resulting in decreased levels of FSH
w xreceptor mRNA in Sertoli cells 20 . Thus, while
cAMP positively regulates FSH receptor gene tran-
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scription in granulosa cells, it negatively regulates the
FSH receptor gene in Sertoli cells. These differences
between FSH receptor gene regulation by cAMP in
Sertoli cells and granulosa cells suggests that differ-
ent cell-specific trans-factors function in these cells
to differentially regulate FSH receptor-gene transcrip-
tions. Based on the studies presented above, we
conclude that the effect FSH on FSH receptor mRNA
occurs in two phases. The first phase lasts for about 6
h following hormone addition and is characterized by
a 50% reduction in the FSH receptor mRNA level.
The second phase starts about 6 h after hormone
addition and is characterized by an increase in FSH
receptor mRNA levels that continues until 3 days
after hormone addition. It is not known whether the
downregulation effect of FSH on its receptor was a
direct effect on mediated via some other factor pro-
duced by granulosa cells. However, the FSH-induced
decline in FSH receptors may be an important com-
ponent in the diminishing responsiveness to FSH and
may play a role in the selection of the dominant
follicles.
An interesting finding in our previous experiments
was that PMA appears to have the ability to reduce
the FSH receptor mRNA. Although 8-Br–cAMP was
unable to decrease FSH receptor mRNA, the effects
of PMA indicated that activation of PKC caused a
w xrapid decrease in FSH mRNA in granulosa cells 14 .
In the present experiment, the time course of the
effect of PMA on FSH receptor mRNA confirmed
the negative effect of PMA and subsequent increase
above the control level by 48 h incubation. These
results ruled out a toxic or non-specific negative
effect of PMA on the cells. Although the effects of
addition of PMA mimicked the time course of the
effects of FSH on FSH receptor mRNA, the suppres-
sion induced by PMA tended to last longer than that
induced by FSH.
w xH-7, a PKC inhibitor 21 , abolished the FSH-
stimulated decrease in FSH receptor mRNA. Since
cAMP had no effect on FSH receptor mRNA down-
w xregulation 14 , the inhibitory effects of H-7 were
most likely attributable to the inhibition of PKC.
Taken together, these findings suggest that the cAMP
cascade may be related to the increase in FSH recep-
tor mRNA levels and at the same time, that the other
cascade, PKC, may have an effect on the decrease in
the levels of FSH receptor mRNA. Thus, FSH treat-
ment with certain concentrations of H-7, which may
interfere with the C kinase cascade, had a elevating
effect on the FSH receptor mRNA levels. This stimu-
latory effect of FSH on FSH receptor mRNA at 6 h
of incubation may be mediated by the cAMP cascade,
which is masked by PKC in the absence of H-7.
The above findings indicate that activation of PKC
is capable of causing a decrease in the level of FSH
receptor mRNA, and that FSH induced downregula-
tion of FSH receptor mRNA requires the activity of
PKC. However, co-treatment with bisindolyl-
maleimide reversed only around 50% of the FSH
effect on FSH receptor transcripts. The persistence of
a significant FSH effect on FSH receptor mRNA with
selective blockade may reflect a dual involvement of
PKC-dependent and -independent pathways.
Half-life studies were performed to investigate
whether there was any change in the stability of FSH
receptor mRNA following PMA treatment. Incuba-
tion with the RNA polymerase inhibitor actinomycin-
D was performed in the absence of PMA and follow-
ing incubation with PMA. The half-life study re-
vealed no change in the stability of the FSH receptor
mRNA following PMA treatment. This suggests that
a change in the rate of FSH receptor gene transcrip-
tion is responsible for the reduction in the steady-state
levels of FSH receptor mRNA. However, nuclear
run-on assay showed that the detection of the effect
of PMA on FSH receptor transcription is difficult,
probably because the basal level of FSH receptor
transcription is not high enough to detect the in-
hibitory effect of PMA in this cell culture system
 .data not shown .
FSH receptor promoter dose not contain a conven-
tional TATA box immediately up-stream from the
two start sites, nor does it have a conventional CAAT
box. Another feature of the FSH receptor gene pro-
moter was the presence of a consensus sequence for
an AP-1-binding site at position y214. AP-1 is a
transcriptional factor that interacts with the promoters
w xof phorbol ester-inducible genes 22 .
Clearly, more work is needed to fully understand
the involvement of protein kinase A and C in the
FSH-induced downregulation of FSH receptor.
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